Page last updated: 2024-09-05

gp 531 and Heart Disease, Ischemic

gp 531 has been researched along with Heart Disease, Ischemic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hale, SL; Kloner, RA1
Buggé, CJ; Bullough, DA; Kurz, MA; Mullane, KM; Young, MA1

Other Studies

2 other study(ies) available for gp 531 and Heart Disease, Ischemic

ArticleYear
Cardioprotection with adenosine-regulating agent, GP531: effects on no-reflow, infarct size, and blood flow following ischemia/ reperfusion in the rabbit.
    Journal of cardiovascular pharmacology and therapeutics, 2010, Volume: 15, Issue:1

    Topics: Adenosine; Aminoimidazole Carboxamide; Analysis of Variance; Animals; Deoxyribonucleosides; Disease Models, Animal; Hemodynamics; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Rabbits; Random Allocation

2010
Cardioprotection with a novel adenosine regulating agent mediated by intravascular adenosine.
    European journal of pharmacology, 1997, Mar-19, Volume: 322, Issue:2-3

    Topics: Adenosine; Aminoimidazole Carboxamide; Animals; Cardiotonic Agents; Deoxyribonucleosides; Female; Hemodynamics; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Swine; Swine, Miniature

1997